Skip to main content

ORIGINAL RESEARCH article

Front. Microbiol.
Sec. Phage Biology
Volume 15 - 2024 | doi: 10.3389/fmicb.2024.1513081
This article is part of the Research Topic Bacteriophages, Prophages, and Their Products: Regulating Bacterial Populations View all 9 articles

Vic9 Mycobacteriophage: The First Subcluster B2 Phage Isolated in Russia

Provisionally accepted
  • 1 Laboratory of Molecular Genetics of Microorganisms, Federal Scientific Clinical Center of Physical and Chemical Medicine, Federal Medical & Biological Agency of Russia, Moscow, Moscow Oblast, Russia
  • 2 Federal Scientific Clinical Center of Physical and Chemical Medicine, Federal Medical & Biological Agency of Russia, Moscow, Moscow Oblast, Russia
  • 3 Federal Research Centre 'Fundamentals of Biotechnology' of the Russian Academy of Sciences, Moscow, Russia, Moscow, Moscow Oblast, Russia
  • 4 State Research Center for Applied Microbiology and Biotechnology, Obolensk, Russia
  • 5 Lomonosov Moscow State University, Moscow, Moscow, Russia
  • 6 Federal State Budget Institution National Medical Research Radiology Center of the Ministry of Healthcare of the Russian Federation (FSBI NMRRC), Moscow, Moscow Oblast, Russia

The final, formatted version of the article will be published soon.

    Mycobacteriophages are viruses that specifically infect bacteria of the Mycobacterium genus. A substantial collection of mycobacteriophages has been isolated and characterized, offering valuable insights into their diversity and evolution. This collection also holds significant potential for therapeutic applications, particularly as an alternative to antibiotics in combating drug-resistant bacterial strains. In this study, we report the isolation and characterization of a new mycobacteriophage, Vic9, using Mycobacterium smegmatis mc(2)155 as the host strain. Vic9 has been classified within the B2 subcluster of the B cluster. Morphological analysis revealed that Vic9 has a structure typical of siphophages from this subcluster and forms characteristic plaques. The phage adsorbs onto host strain cells within 30 min, and according to one-step growth experiments, its latent period lasts about 90 min, followed by a growth period of 150 min, with an average yield of approximately 68 phage particles per infected cell. In host range experiments, Vic9 efficiently lysed the host strain and also exhibited the ability to lyse M. tuberculosis H37Rv, albeit with a low efficiency of plating (EOP ≈ 2×10⁻⁵), a typical feature of B2 phages. No lysis was observed in other tested mycobacterial species. The genome of Vic9 comprises 67,543 bp of double-stranded DNA and encodes 89 open reading frames. Our analysis revealed unique features in Vic9, despite its close relationship to other B2 subcluster phages, highlighting its distinct characteristics even among closely related phages. Particularly noteworthy was the discovery of a distinct 435 bp sequence within the gene cluster responsible for queuosine biosynthesis, as well as a recombination event within the structural cassette region (Vic_0033-Vic_0035) among members of the B1, B2, and B3 subclusters. These genetic features are of interest for further research, as they may reveal new mechanisms of phage-bacteria interactions and their potential for developing novel phage therapy methods

    Keywords: Mycobacteriophages, Mycobacterium tuberculosis, Host range, B cluster, One-step growth curve

    Received: 17 Oct 2024; Accepted: 12 Dec 2024.

    Copyright: © 2024 Zaychikova, Malakhova, Bespiatykh, Kornienko, Klimina, Strokach, Gorodnichev, German, Fursov, Bagrov, Vnukova, Gracheva, Kazyulina, Shleeva and Shitikov. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Marina Zaychikova, Laboratory of Molecular Genetics of Microorganisms, Federal Scientific Clinical Center of Physical and Chemical Medicine, Federal Medical & Biological Agency of Russia, Moscow, Moscow Oblast, Russia

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.